Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Cochrane on Glucose Monitoring to Manage GDM

Cochrane, 2017 Oct 29; Raman, Shepherd, et al

Blood glucose monitoring is an important strategy for managing gestational diabetes, but there is uncertainty about which methods are best, according to a Cochrane review of 11 trials involving nearly 1,300 individuals. Based on low- or very low-quality evidence, there were no clear differences for:

  • Pre-eclampsia or hypertension, cesarean section, or induction of labor in women receiving care via telemedicine vs standard care.
  • Their babies being born large-for-gestational age, developing a serious morbidity, or having hypoglycemia.
  • Pre-eclampsia or cesarean section in women who self-monitored glucose levels vs those who received periodic glucose monitoring.
  • Their babies dying, being born large-for-gestational age, or developing hypoglycemia.
  • Pre-eclampsia, cesarean section, or perineal trauma in women who underwent postprandial vs preprandial glucose monitoring.

Babies born to women who had postprandial glucose monitoring were less likely to be born large-for-gestational age.

Citation:

Raman P, Shepherd E, Dowswell T, Middleton P, Crowther C. Different methods and settings for glucose monitoring for gestational diabetes during pregnancy. Cochrane Database of Syst Rev. 2017, Issue 10. Art. No.: CD011069. doi:10.1002/14651858.CD011069.pub2.